Pacira BioSciences, Inc. revenue growth has been varied year-over-year.

What is PCRX's revenue growth rate?

Historical revenue data is available for Pacira BioSciences, Inc. to analyze growth trends.

How fast is PCRX earnings growing?

Earnings growth data is available for Pacira BioSciences, Inc. analysis.

What is PCRX's profit margin?

Profit margin data is available for Pacira BioSciences, Inc..

PCRX Revenue & Earnings Growth Analysis 2026 - Is Pacira BioSciences, Inc. Growing?

Growth Summary

Pacira BioSciences, Inc. (PCRX) has experienced challenges in growth. The company operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.

Latest Revenue

$0.00

Net Income

$-99560000.00

5-Year Revenue CAGR

N/A

4 years of data

Net Margin

N/A

Latest period

Revenue Growth Over Time

Historical revenue and profitability trends for Pacira BioSciences, Inc.

The chart above illustrates Pacira BioSciences, Inc.'s revenue trajectory over the past 4 years. The revenue pattern shows the challenges the company has faced in recent periods.

Year-over-Year Growth Rates

Annual percentage change in revenue and earnings

Growth rates provide insight into the momentum of Pacira BioSciences, Inc.'s business.

Profit Margin Trends

How efficiently Pacira BioSciences, Inc. converts revenue into profit

Understanding Profit Margins

Profit margins reveal how much of each dollar of revenue Pacira BioSciences, Inc. retains at different stages:

Gross Margin (N/A%): What remains after direct production costs
Operating Margin (N/A%): Profit from core operations before interest and taxes
Net Margin (N/A%): Final profit after all expenses

Future Growth Outlook

Analyst estimates and forward-looking indicators

EPS Estimate 2026

$2.64

Current: $-2.15

EPS Estimate 2027

$3.49

32.1% expected growth

Price Target

$28.71

Analyst consensus

What Analysts Are Saying

Wall Street analysts project Pacira BioSciences, Inc. to continue growing earnings in the coming year. The consensus analyst rating is 3.3333 based on 6 analysts.

Growth Analysis Conclusion

Based on our comprehensive analysis, Pacira BioSciences, Inc. (PCRX) demonstrates declining growth characteristics.

Key Takeaways:

Revenue Growth:
Profitability: shows the company is investing in growth over short-term profits
Efficiency:

Investment Considerations

This growth analysis provides a comprehensive view of Pacira BioSciences, Inc.'s historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.